speb/financial-data huggingface dataset:
BONE.V income_statement (annual, 2021-06-30) — Other Operating Expenses: 729588.00
BONE.V balance_sheet (annual, 2021-06-30) — Other Properties: 9981688.00
BONE.V balance_sheet (annual, 2021-06-30) — Other Short Term Investments: 0.00
BONE.V balance_sheet (annual, 2021-06-30) — Payables: 418349.00
BONE.V balance_sheet (annual, 2021-06-30) — Payables And Accrued Expenses: 466341.00
BONE.V balance_sheet (annual, 2021-06-30) — Prepaid Assets: 104241.00
BONE.V income_statement (annual, 2021-06-30) — Pretax Income: -1095430.00
BONE.V cash_flow (annual, 2021-06-30) — Proceeds From Stock Option Exercised: 400755.00
BONE.V cash_flow (annual, 2021-06-30) — Purchase Of PPE: -283364.00
BONE.V balance_sheet (annual, 2021-06-30) — Receivables: 2802.00
BONE.V income_statement (annual, 2021-06-30) — Reconciled Cost Of Revenue: 10160.00
BONE.V income_statement (annual, 2021-06-30) — Reconciled Depreciation: 10160.00
BONE.V income_statement (annual, 2021-06-30) — Rent And Landing Fees: 24862.00
BONE.V income_statement (annual, 2021-06-30) — Rent Expense Supplemental: 24862.00
BONE.V cash_flow (annual, 2021-06-30) — Repayment Of Debt: -12516.00
BONE.V balance_sheet (annual, 2021-06-30) — Retained Earnings: -27405522.00
BONE.V income_statement (annual, 2021-06-30) — Salaries And Wages: 203438.00
BONE.V income_statement (annual, 2021-06-30) — Selling And Marketing Expense: 7819.00
BONE.V income_statement (annual, 2021-06-30) — Selling General And Administration: 339754.00
BONE.V balance_sheet (annual, 2021-06-30) — Share Issued: 144311099.00
BONE.V income_statement (annual, 2021-06-30) — Special Income Charges: 0.00
BONE.V cash_flow (annual, 2021-06-30) — Stock Based Compensation: 203438.00
BONE.V balance_sheet (annual, 2021-06-30) — Stockholders Equity: 9647090.00
BONE.V balance_sheet (annual, 2021-06-30) — Tangible Book Value: 9647090.00
BONE.V income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
BONE.V income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.00
BONE.V balance_sheet (annual, 2021-06-30) — Taxes Receivable: 2802.00
BONE.V balance_sheet (annual, 2021-06-30) — Total Assets: 10209314.00
BONE.V balance_sheet (annual, 2021-06-30) — Total Capitalization: 9687090.00
BONE.V balance_sheet (annual, 2021-06-30) — Total Debt: 95883.00
BONE.V balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 9647090.00
BONE.V income_statement (annual, 2021-06-30) — Total Expenses: 1079502.00
BONE.V balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 562224.00
BONE.V balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 9981688.00
BONE.V balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 40000.00
BONE.V income_statement (annual, 2021-06-30) — Total Other Finance Cost: 9626.00
BONE.V income_statement (annual, 2021-06-30) — Total Unusual Items: -902.00
BONE.V income_statement (annual, 2021-06-30) — Total Unusual Items Excluding Goodwill: -902.00
BONE.V cash_flow (annual, 2021-06-30) — Unrealized Gain Loss On Investment Securities: 0.00
BONE.V balance_sheet (annual, 2021-06-30) — Working Capital: -294598.00
BONE.V income_statement (annual, 2021-06-30) — Write Off: 0.00
BONE.V income_statement (annual, 2022-06-30) — +Operating Expense: 878089.00
BONE.V income_statement (annual, 2022-06-30) — +Total Revenue: 0.00
BONE.V balance_sheet (annual, 2022-06-30) — Accounts Payable: 512979.00
BONE.V cash_flow (annual, 2022-06-30) — Asset Impairment Charge: 23930.00
BONE.V income_statement (annual, 2022-06-30) — Basic Average Shares: 151486182.00
BONE.V income_statement (annual, 2022-06-30) — Basic EPS: -0.01
BONE.V cash_flow (annual, 2022-06-30) — Beginning Cash Position: 120583.00
BONE.V cash_flow (annual, 2022-06-30) — Capital Expenditure: -43718.00
BONE.V balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 15971.00
BONE.V balance_sheet (annual, 2022-06-30) — Capital Stock: 35478066.00
BONE.V balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 31038.00
BONE.V balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 71193.00
BONE.V balance_sheet (annual, 2022-06-30) — Cash Financial: 31038.00
BONE.V cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 656355.00
BONE.V cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -43718.00
BONE.V cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Operating Activities: -702182.00
BONE.V cash_flow (annual, 2022-06-30) — Change In Payables And Accrued Expense: 74410.00
BONE.V cash_flow (annual, 2022-06-30) — Change In Prepaid Assets: 104241.00
BONE.V cash_flow (annual, 2022-06-30) — Change In Receivables: 501.00
BONE.V cash_flow (annual, 2022-06-30) — Change In Working Capital: 179152.00
BONE.V cash_flow (annual, 2022-06-30) — Changes In Cash: -89545.00
BONE.V balance_sheet (annual, 2022-06-30) — Common Stock: 35478066.00
BONE.V balance_sheet (annual, 2022-06-30) — Common Stock Equity: 9261324.00
BONE.V cash_flow (annual, 2022-06-30) — Common Stock Issuance: 544744.00
BONE.V income_statement (annual, 2022-06-30) — Cost Of Revenue: 11054.00
BONE.V balance_sheet (annual, 2022-06-30) — Current Accrued Expenses: 47992.00
BONE.V balance_sheet (annual, 2022-06-30) — Current Assets: 73494.00
BONE.V balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 11625.00
BONE.V balance_sheet (annual, 2022-06-30) — Current Debt: 57257.00
BONE.V balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 68882.00
BONE.V balance_sheet (annual, 2022-06-30) — Current Liabilities: 629853.00
BONE.V cash_flow (annual, 2022-06-30) — Depreciation: 11054.00
BONE.V cash_flow (annual, 2022-06-30) — Depreciation Amortization Depletion: 11054.00
BONE.V cash_flow (annual, 2022-06-30) — Depreciation And Amortization: 11054.00
BONE.V income_statement (annual, 2022-06-30) — Diluted Average Shares: 151486182.00
BONE.V income_statement (annual, 2022-06-30) — Diluted EPS: -0.01
BONE.V income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: -1079234.00
BONE.V income_statement (annual, 2022-06-30) — EBIT: -1073834.00
BONE.V income_statement (annual, 2022-06-30) — EBITDA: -1062780.00
BONE.V cash_flow (annual, 2022-06-30) — End Cash Position: 31038.00
BONE.V cash_flow (annual, 2022-06-30) — Financing Cash Flow: 656355.00
BONE.V cash_flow (annual, 2022-06-30) — Free Cash Flow: -702182.00
BONE.V income_statement (annual, 2022-06-30) — Gain On Sale Of Security: -154247.00
BONE.V balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 2268014.00
BONE.V income_statement (annual, 2022-06-30) — General And Administrative Expense: 128445.00
BONE.V balance_sheet (annual, 2022-06-30) — Gross PPE: 9862029.00
BONE.V income_statement (annual, 2022-06-30) — Gross Profit: -11054.00
BONE.V cash_flow (annual, 2022-06-30) — Income Tax Paid Supplemental Data: 0.00
BONE.V income_statement (annual, 2022-06-30) — Interest Expense: 5400.00
BONE.V income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 5400.00
BONE.V cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 0.00
BONE.V balance_sheet (annual, 2022-06-30) — Invested Capital: 9358581.00
BONE.V cash_flow (annual, 2022-06-30) — Investing Cash Flow: -43718.00
BONE.V cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 544744.00
BONE.V balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 4346.00
BONE.V balance_sheet (annual, 2022-06-30) — Long Term Debt: 40000.00
BONE.V balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 44346.00
BONE.V cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -13183.00
BONE.V cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 544744.00
BONE.V balance_sheet (annual, 2022-06-30) — Net Debt: 66219.00
BONE.V income_statement (annual, 2022-06-30) — Net Income: -1079234.00
BONE.V income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -1079234.00
BONE.V income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -1079234.00
BONE.V income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -1079234.00
BONE.V income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -1079234.00
BONE.V cash_flow (annual, 2022-06-30) — Net Income From Continuing Operations: -1079234.00
BONE.V income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -1079234.00
BONE.V income_statement (annual, 2022-06-30) — Net Interest Income: -11914.00
BONE.V cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -13183.00
BONE.V cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -13183.00
BONE.V income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -11914.00
BONE.V cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -47431.00
BONE.V cash_flow (annual, 2022-06-30) — Net Other Investing Changes: -43718.00
BONE.V balance_sheet (annual, 2022-06-30) — Net PPE: 9862029.00
BONE.V cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -43718.00
BONE.V balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 9261324.00
BONE.V balance_sheet (annual, 2022-06-30) — Non Current Prepaid Assets: 0.00
BONE.V income_statement (annual, 2022-06-30) — Normalized EBITDA: -884603.00
BONE.V income_statement (annual, 2022-06-30) — Normalized Income: -901057.00
BONE.V cash_flow (annual, 2022-06-30) — Operating Cash Flow: -702182.00
BONE.V income_statement (annual, 2022-06-30) — Operating Income: -889143.00
BONE.V income_statement (annual, 2022-06-30) — Operating Revenue: 0.00
BONE.V balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 153870699.00
BONE.V balance_sheet (annual, 2022-06-30) — Other Current Borrowings: 57257.00
BONE.V income_statement (annual, 2022-06-30) — Other Gand A: 103465.00
BONE.V income_statement (annual, 2022-06-30) — Other Income Expense: -178177.00
BONE.V cash_flow (annual, 2022-06-30) — Other Non Cash Items: 7524.00
BONE.V income_statement (annual, 2022-06-30) — Other Operating Expenses: 732420.00
BONE.V balance_sheet (annual, 2022-06-30) — Other Properties: 9862029.00
BONE.V balance_sheet (annual, 2022-06-30) — Other Short Term Investments: 40155.00
BONE.V balance_sheet (annual, 2022-06-30) — Payables: 512979.00
BONE.V balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 560971.00
BONE.V balance_sheet (annual, 2022-06-30) — Prepaid Assets: 0.00
BONE.V income_statement (annual, 2022-06-30) — Pretax Income: -1079234.00
BONE.V cash_flow (annual, 2022-06-30) — Proceeds From Stock Option Exercised: 172225.00
BONE.V cash_flow (annual, 2022-06-30) — Purchase Of PPE: -43718.00
BONE.V balance_sheet (annual, 2022-06-30) — Receivables: 2301.00
BONE.V income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 11054.00
BONE.V income_statement (annual, 2022-06-30) — Reconciled Depreciation: 11054.00
BONE.V income_statement (annual, 2022-06-30) — Rent And Landing Fees: 24980.00
BONE.V income_statement (annual, 2022-06-30) — Rent Expense Supplemental: 24980.00
BONE.V cash_flow (annual, 2022-06-30) — Repayment Of Debt: -13183.00
BONE.V balance_sheet (annual, 2022-06-30) — Retained Earnings: -28484756.00
BONE.V income_statement (annual, 2022-06-30) — Salaries And Wages: 0.00
BONE.V income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 17224.00
BONE.V income_statement (annual, 2022-06-30) — Selling General And Administration: 145669.00
BONE.V balance_sheet (annual, 2022-06-30) — Share Issued: 153870699.00
BONE.V income_statement (annual, 2022-06-30) — Special Income Charges: -23930.00
BONE.V cash_flow (annual, 2022-06-30) — Stock Based Compensation: 0.00
BONE.V balance_sheet (annual, 2022-06-30) — Stockholders Equity: 9261324.00
BONE.V balance_sheet (annual, 2022-06-30) — Tangible Book Value: 9261324.00
BONE.V income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
BONE.V income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
BONE.V balance_sheet (annual, 2022-06-30) — Taxes Receivable: 2301.00
BONE.V balance_sheet (annual, 2022-06-30) — Total Assets: 9935523.00
BONE.V balance_sheet (annual, 2022-06-30) — Total Capitalization: 9301324.00
BONE.V balance_sheet (annual, 2022-06-30) — Total Debt: 113228.00
BONE.V balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 9261324.00
BONE.V income_statement (annual, 2022-06-30) — Total Expenses: 889143.00
BONE.V balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 674199.00
BONE.V balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 9862029.00
BONE.V balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 44346.00
BONE.V income_statement (annual, 2022-06-30) — Total Other Finance Cost: 6514.00
BONE.V income_statement (annual, 2022-06-30) — Total Unusual Items: -178177.00
BONE.V income_statement (annual, 2022-06-30) — Total Unusual Items Excluding Goodwill: -178177.00
BONE.V cash_flow (annual, 2022-06-30) — Unrealized Gain Loss On Investment Securities: 155392.00
BONE.V balance_sheet (annual, 2022-06-30) — Working Capital: -556359.00
BONE.V income_statement (annual, 2022-06-30) — Write Off: 23930.00
BONE.V income_statement (annual, 2023-06-30) — +Operating Expense: 900853.00
BONE.V income_statement (annual, 2023-06-30) — +Total Revenue: 0.00
BONE.V balance_sheet (annual, 2023-06-30) — Accounts Payable: 418371.00
BONE.V cash_flow (annual, 2023-06-30) — Asset Impairment Charge: 0.00
BONE.V income_statement (annual, 2023-06-30) — Basic Average Shares: 165074639.00
BONE.V income_statement (annual, 2023-06-30) — Basic EPS: -0.01
BONE.V cash_flow (annual, 2023-06-30) — Beginning Cash Position: 31038.00
BONE.V cash_flow (annual, 2023-06-30) — Capital Expenditure: -258542.00
BONE.V balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 4346.00
BONE.V balance_sheet (annual, 2023-06-30) — Capital Stock: 36810105.00
BONE.V balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 148219.00
BONE.V balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 153108.00
BONE.V balance_sheet (annual, 2023-06-30) — Cash Financial: 148219.00
BONE.V cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 1410450.00
BONE.V cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -258542.00
BONE.V cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Operating Activities: -1034727.00
BONE.V cash_flow (annual, 2023-06-30) — Change In Payables And Accrued Expense: -45239.00
BONE.V cash_flow (annual, 2023-06-30) — Change In Prepaid Assets: -78332.00
BONE.V cash_flow (annual, 2023-06-30) — Change In Receivables: -4404.00
BONE.V cash_flow (annual, 2023-06-30) — Change In Working Capital: -127975.00
BONE.V cash_flow (annual, 2023-06-30) — Changes In Cash: 117181.00
BONE.V balance_sheet (annual, 2023-06-30) — Common Stock: 36810105.00
BONE.V balance_sheet (annual, 2023-06-30) — Common Stock Equity: 9781405.00
BONE.V cash_flow (annual, 2023-06-30) — Common Stock Issuance: 1086300.00
BONE.V income_statement (annual, 2023-06-30) — Cost Of Revenue: 11501.00
BONE.V balance_sheet (annual, 2023-06-30) — Current Accrued Expenses: 47992.00
BONE.V balance_sheet (annual, 2023-06-30) — Current Assets: 225145.00
BONE.V balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 4346.00
BONE.V balance_sheet (annual, 2023-06-30) — Current Debt: 102657.00
BONE.V balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 107003.00
BONE.V balance_sheet (annual, 2023-06-30) — Current Liabilities: 573366.00
BONE.V cash_flow (annual, 2023-06-30) — Depreciation: 11501.00
BONE.V cash_flow (annual, 2023-06-30) — Depreciation Amortization Depletion: 11501.00
BONE.V cash_flow (annual, 2023-06-30) — Depreciation And Amortization: 11501.00
BONE.V income_statement (annual, 2023-06-30) — Diluted Average Shares: 165074639.00
BONE.V income_statement (annual, 2023-06-30) — Diluted EPS: -0.01
BONE.V income_statement (annual, 2023-06-30) — Diluted NI Availto Com Stockholders: -903885.00
BONE.V income_statement (annual, 2023-06-30) — EBIT: -898485.00
BONE.V income_statement (annual, 2023-06-30) — EBITDA: -886984.00
BONE.V cash_flow (annual, 2023-06-30) — End Cash Position: 148219.00
BONE.V cash_flow (annual, 2023-06-30) — Financing Cash Flow: 1410450.00
BONE.V cash_flow (annual, 2023-06-30) — Free Cash Flow: -1034727.00
BONE.V income_statement (annual, 2023-06-30) — Gain On Sale Of Security: -40276.00
BONE.V balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 2357441.00
BONE.V income_statement (annual, 2023-06-30) — General And Administrative Expense: 117213.00
BONE.V balance_sheet (annual, 2023-06-30) — Gross PPE: 10116626.00
BONE.V income_statement (annual, 2023-06-30) — Gross Profit: -11501.00
BONE.V cash_flow (annual, 2023-06-30) — Income Tax Paid Supplemental Data: 0.00
BONE.V income_statement (annual, 2023-06-30) — Interest Expense: 5400.00
BONE.V income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 5400.00
BONE.V cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 0.00
BONE.V balance_sheet (annual, 2023-06-30) — Invested Capital: 9884062.00
BONE.V cash_flow (annual, 2023-06-30) — Investing Cash Flow: -258542.00
BONE.V cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 1086300.00
BONE.V balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 0.00
BONE.V cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -13516.00
BONE.V cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 1086300.00
BONE.V income_statement (annual, 2023-06-30) — Net Income: -903885.00
BONE.V income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -903885.00
BONE.V income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -903885.00
BONE.V income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -903885.00
BONE.V income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -903885.00
BONE.V cash_flow (annual, 2023-06-30) — Net Income From Continuing Operations: -903885.00
BONE.V income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -903885.00
BONE.V income_statement (annual, 2023-06-30) — Net Interest Income: -8180.00
BONE.V cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: -13516.00
BONE.V cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: -13516.00
BONE.V income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -8180.00
BONE.V cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -41688.00
BONE.V cash_flow (annual, 2023-06-30) — Net Other Investing Changes: -258542.00
BONE.V balance_sheet (annual, 2023-06-30) — Net PPE: 10116626.00
BONE.V cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -258542.00
BONE.V balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 9781405.00
BONE.V balance_sheet (annual, 2023-06-30) — Non Current Prepaid Assets: 13000.00
BONE.V income_statement (annual, 2023-06-30) — Normalized EBITDA: -846708.00
BONE.V income_statement (annual, 2023-06-30) — Normalized Income: -863609.00
BONE.V cash_flow (annual, 2023-06-30) — Operating Cash Flow: -1034727.00
BONE.V income_statement (annual, 2023-06-30) — Operating Income: -912354.00
BONE.V income_statement (annual, 2023-06-30) — Operating Revenue: 0.00
BONE.V balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 180012343.00
BONE.V balance_sheet (annual, 2023-06-30) — Other Current Borrowings: 102657.00
BONE.V balance_sheet (annual, 2023-06-30) — Other Equity Interest: 2500.00
BONE.V income_statement (annual, 2023-06-30) — Other Gand A: 93834.00
BONE.V income_statement (annual, 2023-06-30) — Other Income Expense: 16649.00
BONE.V cash_flow (annual, 2023-06-30) — Other Non Cash Items: -49634.00
BONE.V income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 56925.00
BONE.V income_statement (annual, 2023-06-30) — Other Operating Expenses: 676998.00
BONE.V balance_sheet (annual, 2023-06-30) — Other Properties: 10116626.00
BONE.V balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 4889.00
BONE.V balance_sheet (annual, 2023-06-30) — Payables: 418371.00
BONE.V balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 466363.00
BONE.V balance_sheet (annual, 2023-06-30) — Prepaid Assets: 65332.00
BONE.V income_statement (annual, 2023-06-30) — Pretax Income: -903885.00
BONE.V cash_flow (annual, 2023-06-30) — Proceeds From Stock Option Exercised: 379354.00
BONE.V cash_flow (annual, 2023-06-30) — Purchase Of PPE: -258542.00
BONE.V balance_sheet (annual, 2023-06-30) — Receivables: 6705.00
BONE.V income_statement (annual, 2023-06-30) — Reconciled Cost Of Revenue: 11501.00
BONE.V income_statement (annual, 2023-06-30) — Reconciled Depreciation: 11501.00
BONE.V income_statement (annual, 2023-06-30) — Rent And Landing Fees: 23379.00
BONE.V income_statement (annual, 2023-06-30) — Rent Expense Supplemental: 23379.00
BONE.V cash_flow (annual, 2023-06-30) — Repayment Of Debt: -13516.00
BONE.V balance_sheet (annual, 2023-06-30) — Retained Earnings: -29388641.00
BONE.V income_statement (annual, 2023-06-30) — Selling And Marketing Expense: 106642.00
BONE.V income_statement (annual, 2023-06-30) — Selling General And Administration: 223855.00
BONE.V balance_sheet (annual, 2023-06-30) — Share Issued: 180012343.00
BONE.V income_statement (annual, 2023-06-30) — Special Income Charges: 0.00
BONE.V balance_sheet (annual, 2023-06-30) — Stockholders Equity: 9781405.00
BONE.V balance_sheet (annual, 2023-06-30) — Tangible Book Value: 9781405.00
BONE.V income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
BONE.V income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
BONE.V balance_sheet (annual, 2023-06-30) — Taxes Receivable: 6705.00
BONE.V balance_sheet (annual, 2023-06-30) — Total Assets: 10354771.00
BONE.V balance_sheet (annual, 2023-06-30) — Total Capitalization: 9781405.00
BONE.V balance_sheet (annual, 2023-06-30) — Total Debt: 107003.00
BONE.V balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 9781405.00
BONE.V income_statement (annual, 2023-06-30) — Total Expenses: 912354.00
BONE.V balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 573366.00
BONE.V balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 10129626.00
BONE.V balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
BONE.V income_statement (annual, 2023-06-30) — Total Other Finance Cost: 2780.00
BONE.V income_statement (annual, 2023-06-30) — Total Unusual Items: -40276.00
BONE.V income_statement (annual, 2023-06-30) — Total Unusual Items Excluding Goodwill: -40276.00
BONE.V cash_flow (annual, 2023-06-30) — Unrealized Gain Loss On Investment Securities: 35266.00
BONE.V balance_sheet (annual, 2023-06-30) — Working Capital: -348221.00
BONE.V income_statement (annual, 2023-06-30) — Write Off: 0.00
BONE.V income_statement (annual, 2024-06-30) — +Operating Expense: 932199.00
BONE.V income_statement (annual, 2024-06-30) — +Total Revenue: 0.00
BONE.V balance_sheet (annual, 2024-06-30) — Accounts Payable: 502321.00
BONE.V income_statement (annual, 2024-06-30) — Basic Average Shares: 194960582.00
BONE.V income_statement (annual, 2024-06-30) — Basic EPS: 0.00
BONE.V cash_flow (annual, 2024-06-30) — Beginning Cash Position: 148219.00
BONE.V balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 32177.00
BONE.V balance_sheet (annual, 2024-06-30) — Capital Stock: 38247111.00
BONE.V balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 171841.00
BONE.V balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 179923.00
BONE.V balance_sheet (annual, 2024-06-30) — Cash Financial: 171841.00
BONE.V cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 1539223.00
BONE.V cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -599879.00
BONE.V cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Operating Activities: -915722.00
BONE.V cash_flow (annual, 2024-06-30) — Change In Payables And Accrued Expense: -7763.00
BONE.V cash_flow (annual, 2024-06-30) — Change In Prepaid Assets: 50249.00
BONE.V cash_flow (annual, 2024-06-30) — Change In Receivables: -14011.00
BONE.V cash_flow (annual, 2024-06-30) — Change In Working Capital: 28475.00
BONE.V cash_flow (annual, 2024-06-30) — Changes In Cash: 23622.00
BONE.V balance_sheet (annual, 2024-06-30) — Common Stock: 38247111.00
BONE.V balance_sheet (annual, 2024-06-30) — Common Stock Equity: 10373469.00
BONE.V cash_flow (annual, 2024-06-30) — Common Stock Issuance: 710800.00
BONE.V income_statement (annual, 2024-06-30) — Cost Of Revenue: 19275.00
BONE.V balance_sheet (annual, 2024-06-30) — Current Accrued Expenses: 55562.00
BONE.V balance_sheet (annual, 2024-06-30) — Current Assets: 228722.00
BONE.V balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 23421.00
BONE.V balance_sheet (annual, 2024-06-30) — Current Debt: 68072.00
BONE.V balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 91493.00
BONE.V balance_sheet (annual, 2024-06-30) — Current Liabilities: 649376.00
BONE.V cash_flow (annual, 2024-06-30) — Depreciation: 19275.00
BONE.V cash_flow (annual, 2024-06-30) — Depreciation Amortization Depletion: 19275.00
BONE.V cash_flow (annual, 2024-06-30) — Depreciation And Amortization: 19275.00
BONE.V income_statement (annual, 2024-06-30) — Diluted Average Shares: 194960582.00
BONE.V income_statement (annual, 2024-06-30) — Diluted EPS: 0.00
BONE.V income_statement (annual, 2024-06-30) — Diluted NI Availto Com Stockholders: -970624.00
BONE.V income_statement (annual, 2024-06-30) — EBIT: -965209.00
BONE.V income_statement (annual, 2024-06-30) — EBITDA: -945934.00
BONE.V cash_flow (annual, 2024-06-30) — End Cash Position: 171841.00
BONE.V cash_flow (annual, 2024-06-30) — Financing Cash Flow: 1539223.00
BONE.V cash_flow (annual, 2024-06-30) — Free Cash Flow: -915722.00
BONE.V income_statement (annual, 2024-06-30) — Gain On Sale Of Security: -2689.00
BONE.V balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 2491993.00
BONE.V income_statement (annual, 2024-06-30) — General And Administrative Expense: 91638.00
BONE.V balance_sheet (annual, 2024-06-30) — Gross PPE: 10842832.00
BONE.V income_statement (annual, 2024-06-30) — Gross Profit: -19275.00
BONE.V cash_flow (annual, 2024-06-30) — Income Tax Paid Supplemental Data: 0.00
BONE.V income_statement (annual, 2024-06-30) — Interest Expense: 5415.00
BONE.V income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 5415.00
BONE.V cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 0.00
BONE.V balance_sheet (annual, 2024-06-30) — Invested Capital: 10481494.00
BONE.V cash_flow (annual, 2024-06-30) — Investing Cash Flow: -599879.00
BONE.V cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 710800.00
BONE.V balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 8756.00
BONE.V balance_sheet (annual, 2024-06-30) — Long Term Debt: 39953.00
BONE.V balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 48709.00
BONE.V cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -23465.00
BONE.V cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 710800.00
BONE.V income_statement (annual, 2024-06-30) — Net Income: -970624.00
BONE.V income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -970624.00
BONE.V income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -970624.00
BONE.V income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -970624.00
BONE.V income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -970624.00
BONE.V cash_flow (annual, 2024-06-30) — Net Income From Continuing Operations: -970624.00
BONE.V income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -970624.00
BONE.V income_statement (annual, 2024-06-30) — Net Interest Income: -20420.00
BONE.V cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: -23465.00
BONE.V cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: -23465.00
BONE.V income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -20420.00
BONE.V cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -103205.00
BONE.V cash_flow (annual, 2024-06-30) — Net Other Investing Changes: -599879.00
BONE.V balance_sheet (annual, 2024-06-30) — Net PPE: 10842832.00
BONE.V balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 10373469.00
BONE.V balance_sheet (annual, 2024-06-30) — Non Current Prepaid Assets: 0.00
BONE.V income_statement (annual, 2024-06-30) — Normalized EBITDA: -943245.00
BONE.V income_statement (annual, 2024-06-30) — Normalized Income: -967935.00
BONE.V cash_flow (annual, 2024-06-30) — Operating Cash Flow: -915722.00
BONE.V income_statement (annual, 2024-06-30) — Operating Income: -951474.00
BONE.V income_statement (annual, 2024-06-30) — Operating Revenue: 0.00
BONE.V balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 209788706.00
BONE.V balance_sheet (annual, 2024-06-30) — Other Current Borrowings: 68072.00
BONE.V balance_sheet (annual, 2024-06-30) — Other Equity Interest: -6370.00
BONE.V income_statement (annual, 2024-06-30) — Other Gand A: 91638.00
BONE.V income_statement (annual, 2024-06-30) — Other Income Expense: 1270.00
BONE.V cash_flow (annual, 2024-06-30) — Other Non Cash Items: 10345.00
BONE.V income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 3959.00
BONE.V income_statement (annual, 2024-06-30) — Other Operating Expenses: 692118.00
BONE.V balance_sheet (annual, 2024-06-30) — Other Properties: 10842832.00
BONE.V balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 8082.00
BONE.V balance_sheet (annual, 2024-06-30) — Payables: 502321.00
BONE.V balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 557883.00
BONE.V balance_sheet (annual, 2024-06-30) — Prepaid Assets: 28083.00
BONE.V income_statement (annual, 2024-06-30) — Pretax Income: -970624.00
BONE.V cash_flow (annual, 2024-06-30) — Proceeds From Stock Option Exercised: 955093.00
BONE.V balance_sheet (annual, 2024-06-30) — Receivables: 20716.00
BONE.V income_statement (annual, 2024-06-30) — Reconciled Cost Of Revenue: 19275.00
BONE.V income_statement (annual, 2024-06-30) — Reconciled Depreciation: 19275.00
BONE.V cash_flow (annual, 2024-06-30) — Repayment Of Debt: -23465.00
BONE.V balance_sheet (annual, 2024-06-30) — Retained Earnings: -30359265.00
BONE.V income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 148443.00
BONE.V income_statement (annual, 2024-06-30) — Selling General And Administration: 240081.00
BONE.V balance_sheet (annual, 2024-06-30) — Share Issued: 209788706.00
BONE.V balance_sheet (annual, 2024-06-30) — Stockholders Equity: 10373469.00
BONE.V balance_sheet (annual, 2024-06-30) — Tangible Book Value: 10373469.00
BONE.V income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
BONE.V income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
BONE.V balance_sheet (annual, 2024-06-30) — Taxes Receivable: 20716.00
BONE.V balance_sheet (annual, 2024-06-30) — Total Assets: 11071554.00
BONE.V balance_sheet (annual, 2024-06-30) — Total Capitalization: 10413422.00
BONE.V balance_sheet (annual, 2024-06-30) — Total Debt: 140202.00
BONE.V balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 10373469.00
BONE.V income_statement (annual, 2024-06-30) — Total Expenses: 951474.00
BONE.V balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 698085.00
BONE.V balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 10842832.00
BONE.V balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 48709.00
BONE.V income_statement (annual, 2024-06-30) — Total Other Finance Cost: 15005.00
BONE.V income_statement (annual, 2024-06-30) — Total Unusual Items: -2689.00
BONE.V income_statement (annual, 2024-06-30) — Total Unusual Items Excluding Goodwill: -2689.00
BONE.V cash_flow (annual, 2024-06-30) — Unrealized Gain Loss On Investment Securities: -3193.00
BONE.V balance_sheet (annual, 2024-06-30) — Working Capital: -420654.00
BONE.V income_statement (quarterly, 2024-09-30) — +Operating Expense: 233189.00
BONE.V income_statement (quarterly, 2024-09-30) — +Total Revenue: 0.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 455366.00
BONE.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 211425880.00
BONE.V income_statement (quarterly, 2024-09-30) — Basic EPS: 0.00
BONE.V cash_flow (quarterly, 2024-09-30) — Beginning Cash Position: 171841.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 25089.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 26697.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Capital Stock: 38574414.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 160199.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 166627.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Cash Financial: 160199.00
BONE.V cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Financing Activities: 337114.00
BONE.V cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Investing Activities: -80033.00
BONE.V cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Operating Activities: -268723.00
BONE.V cash_flow (quarterly, 2024-09-30) — Change In Payables And Accrued Expense: -47672.00
BONE.V cash_flow (quarterly, 2024-09-30) — Change In Prepaid Assets: 18700.00
BONE.V cash_flow (quarterly, 2024-09-30) — Change In Receivables: -4159.00
BONE.V cash_flow (quarterly, 2024-09-30) — Change In Working Capital: -33131.00
BONE.V cash_flow (quarterly, 2024-09-30) — Changes In Cash: -11642.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Common Stock: 38574414.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 10471767.00
BONE.V cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 352550.00
BONE.V income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 5790.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 43812.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Current Assets: 200885.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 24460.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Current Debt: 69432.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 93892.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 593070.00
BONE.V cash_flow (quarterly, 2024-09-30) — Depreciation: 5790.00
BONE.V cash_flow (quarterly, 2024-09-30) — Depreciation Amortization Depletion: 5790.00
BONE.V cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 5790.00
BONE.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 211425880.00
BONE.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.00
BONE.V income_statement (quarterly, 2024-09-30) — Diluted NI Availto Com Stockholders: -246353.00
BONE.V income_statement (quarterly, 2024-09-30) — EBIT: -244993.00
BONE.V income_statement (quarterly, 2024-09-30) — EBITDA: -239203.00
BONE.V cash_flow (quarterly, 2024-09-30) — End Cash Position: 160199.00
BONE.V cash_flow (quarterly, 2024-09-30) — Financing Cash Flow: 337114.00
BONE.V cash_flow (quarterly, 2024-09-30) — Free Cash Flow: -268723.00
BONE.V income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: -2879.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: 2500471.00
BONE.V income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 28043.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Gross PPE: 10906042.00
BONE.V income_statement (quarterly, 2024-09-30) — Gross Profit: -5790.00
BONE.V cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 0.00
BONE.V income_statement (quarterly, 2024-09-30) — Interest Expense: 1360.00
BONE.V income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 1360.00
BONE.V cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 729.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Invested Capital: 10581052.00
BONE.V cash_flow (quarterly, 2024-09-30) — Investing Cash Flow: -80033.00
BONE.V cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 352550.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 2237.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 39853.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 42090.00
BONE.V cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: -7537.00
BONE.V cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 352550.00
BONE.V income_statement (quarterly, 2024-09-30) — Net Income: -246353.00
BONE.V income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: -246353.00
BONE.V income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: -246353.00
BONE.V income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -246353.00
BONE.V income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -246353.00
BONE.V cash_flow (quarterly, 2024-09-30) — Net Income From Continuing Operations: -246353.00
BONE.V income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: -246353.00
BONE.V income_statement (quarterly, 2024-09-30) — Net Interest Income: -4495.00
BONE.V cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: -7537.00
BONE.V cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: -7537.00
BONE.V income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: -4495.00
BONE.V cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: -30399.00
BONE.V cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: -80033.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Net PPE: 10906042.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 10471767.00
BONE.V income_statement (quarterly, 2024-09-30) — Normalized EBITDA: -236324.00
BONE.V income_statement (quarterly, 2024-09-30) — Normalized Income: -243474.00
BONE.V cash_flow (quarterly, 2024-09-30) — Operating Cash Flow: -268723.00
BONE.V income_statement (quarterly, 2024-09-30) — Operating Income: -238979.00
BONE.V income_statement (quarterly, 2024-09-30) — Operating Revenue: 0.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 217289706.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 69432.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Other Equity Adjustments: 2500471.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 2500.00
BONE.V income_statement (quarterly, 2024-09-30) — Other Gand A: 27527.00
BONE.V income_statement (quarterly, 2024-09-30) — Other Income Expense: -2879.00
BONE.V cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 3317.00
BONE.V income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 183702.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Other Properties: 10880953.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 6428.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Payables: 455366.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Payables And Accrued Expenses: 499178.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 9383.00
BONE.V income_statement (quarterly, 2024-09-30) — Pretax Income: -246353.00
BONE.V cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 22500.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Receivables: 24875.00
BONE.V income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 5790.00
BONE.V income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 5790.00
BONE.V income_statement (quarterly, 2024-09-30) — Rent And Landing Fees: 516.00
BONE.V income_statement (quarterly, 2024-09-30) — Rent Expense Supplemental: 516.00
BONE.V cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: -7537.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Retained Earnings: -30605618.00
BONE.V income_statement (quarterly, 2024-09-30) — Salaries And Wages: 0.00
BONE.V income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 21444.00
BONE.V income_statement (quarterly, 2024-09-30) — Selling General And Administration: 49487.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Share Issued: 217289706.00
BONE.V cash_flow (quarterly, 2024-09-30) — Stock Based Compensation: 0.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 10471767.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 10471767.00
BONE.V income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
BONE.V income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 24875.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Total Assets: 11106927.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 10511620.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Total Debt: 135982.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 10471767.00
BONE.V income_statement (quarterly, 2024-09-30) — Total Expenses: 238979.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 635160.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 10906042.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 42090.00
BONE.V income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: 3135.00
BONE.V income_statement (quarterly, 2024-09-30) — Total Unusual Items: -2879.00
BONE.V income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -2879.00
BONE.V cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: 1654.00
BONE.V balance_sheet (quarterly, 2024-09-30) — Working Capital: -392185.00
BONE.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 219537.00
BONE.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 0.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 581100.00
BONE.V income_statement (quarterly, 2024-12-31) — Basic Average Shares: 217466554.00
BONE.V income_statement (quarterly, 2024-12-31) — Basic EPS: 0.00
BONE.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 160199.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 19299.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 20974.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 38648914.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 57875.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 59543.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Cash Financial: 57875.00
BONE.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 67197.00
BONE.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -73534.00
BONE.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -95987.00
BONE.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 118456.00
BONE.V cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 9383.00
BONE.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: -3679.00
BONE.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 124160.00
BONE.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: -102324.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 38648914.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 10312655.00
BONE.V cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
BONE.V income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 5790.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 32000.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 88097.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 20974.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Current Debt: 70793.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 91767.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 704867.00
BONE.V cash_flow (quarterly, 2024-12-31) — Depreciation: 5790.00
BONE.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 5790.00
BONE.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 5790.00
BONE.V income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 217466554.00
BONE.V income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.00
BONE.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -233612.00
BONE.V income_statement (quarterly, 2024-12-31) — EBIT: -230078.00
BONE.V income_statement (quarterly, 2024-12-31) — EBITDA: -224288.00
BONE.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 57875.00
BONE.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 67197.00
BONE.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -95987.00
BONE.V income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -4751.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2500471.00
BONE.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 41154.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 10969252.00
BONE.V income_statement (quarterly, 2024-12-31) — Gross Profit: -5790.00
BONE.V cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
BONE.V income_statement (quarterly, 2024-12-31) — Interest Expense: 3534.00
BONE.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 3534.00
BONE.V cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 370.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: 10423275.00
BONE.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -73534.00
BONE.V cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 39827.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 39827.00
BONE.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -7303.00
BONE.V cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Net Debt: 52745.00
BONE.V income_statement (quarterly, 2024-12-31) — Net Income: -233612.00
BONE.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -233612.00
BONE.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -233612.00
BONE.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -233612.00
BONE.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -233612.00
BONE.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -233612.00
BONE.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -233612.00
BONE.V income_statement (quarterly, 2024-12-31) — Net Interest Income: -3534.00
BONE.V cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -7303.00
BONE.V cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -7303.00
BONE.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -3534.00
BONE.V cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -3500.00
BONE.V cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: -73534.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 10969252.00
BONE.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 10312655.00
BONE.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -219537.00